Federated Hermes, Inc. Adma Biologics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,627,693 shares of ADMA stock, worth $31.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,627,693

Previous 1,969,811 17.37%

Holding current value

$31.1 Million

Previous $22 Million 47.75%

% of portfolio

0.07%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$11.21 - $20.03 $3.84 Million - $6.85 Million	-342,118 Reduced 17.37%	1,627,693 $32.5 Million
Q2 2024 Aug 08, 2024	BUY	$5.98 - $11.18 $1.58 Million - $2.95 Million	263,677 Added 15.45%	1,969,811 $22 Million
Q1 2024 May 14, 2024	BUY	$4.4 - $6.74 $3.96 Million - $6.06 Million	899,122 Added 111.41%	1,706,134 $11.3 Million
Q4 2023 Jan 31, 2024	BUY	$3.08 - $4.52 $104,002 - $152,626	33,767 Added 4.37%	807,012 $3.65 Million
Q3 2023 Nov 13, 2023	BUY	$3.47 - $4.61 $387,359 - $514,618	111,631 Added 16.87%	773,245 $2.77 Million
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $781,085 - $1.06 Million	-250,348 Reduced 27.45%	661,614 $2.44 Million
Q1 2023 May 08, 2023	BUY	$3.01 - $3.87 $1.27 Million - $1.63 Million	420,310 Added 85.49%	911,962 $3.02 Million
Q4 2022 Feb 13, 2023	BUY	$2.47 - $3.88 $408,883 - $642,295	165,540 Added 50.76%	491,652 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $662,007 - $932,680	326,112 New	326,112 $793,000
Q1 2020 May 13, 2020	SELL	$1.5 - $4.59 $34,237 - $104,766	-22,825 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.89 - $5.15 $87,587 - $115,957	22,516 Added 7286.73%	22,825 $91,000
Q3 2018 Nov 13, 2018	BUY	$4.39 - $6.85 $1,356 - $2,116	309 New	309 $2,000

Others Institutions Holding ADMA

# of Institutions

318

Shares Held

184M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.76B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Adma Biologics, Inc. Transaction History